Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lacy

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Atherosclerosis|December 14, 2025
Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formationYa Li, Julian Leberzammer, Xavier Blanchet, et al.
Cardiovascular Research|June 5, 2024
Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent mannerYong Wang, Guo Li, Bingni Chen, et al.
Circulation|February 7, 2025
Ezh2 Shapes T Cell Plasticity to Drive AtherosclerosisCecilia Assunta Bonfiglio, Michael Lacy, Vasiliki Triantafyllidou, et al.
European Heart Journal|July 31, 2020
Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humansAnnelie Shami, Dorothee Atzler, Laura A Bosmans, et al.
Circulation Research|September 14, 2022
The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell FunctionKatrin Nitz, Michael Lacy, Mariaelvy Bianchini, et al.
Nature Communications|June 19, 2021
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular diseaseMichael Lacy, Christina Bürger, Annelie Shami, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Atherosclerosis|December 14, 2025
Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formationYa Li, Julian Leberzammer, Xavier Blanchet, et al.
Cardiovascular Research|June 5, 2024
Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent mannerYong Wang, Guo Li, Bingni Chen, et al.
Circulation|February 7, 2025
Ezh2 Shapes T Cell Plasticity to Drive AtherosclerosisCecilia Assunta Bonfiglio, Michael Lacy, Vasiliki Triantafyllidou, et al.
European Heart Journal|July 31, 2020
Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humansAnnelie Shami, Dorothee Atzler, Laura A Bosmans, et al.
Circulation Research|September 14, 2022
The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell FunctionKatrin Nitz, Michael Lacy, Mariaelvy Bianchini, et al.
Nature Communications|June 19, 2021
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular diseaseMichael Lacy, Christina Bürger, Annelie Shami, et al.
Pageof 2